Once-a-Day Concerta Methylphenidate Versus Three-Times-Daily Methylphenidate in Laboratory and Natural Settings

American Academy of Pediatrics (AAP) - Tập 107 Số 6 - Trang e105-e105 - 2001
William E. Pelham1, Elizabeth M. Gnagy1, Lisa Burrows-MacLean1, Andy Williams1, Gregory A. Fabiano1, Sean M. Morrisey1, Andrea M. Chronis1, Gregory Forehand1, Celeste Nguyen1, Martin T. Hoffman2, Thomas M. Lock2, Karl Fielbelkorn3, Erika K. Coles1, Carlos J. Panahon1, Randi L. Steiner1, David L. Meichenbaum1, Adia N. Onyango1, Gene D. Morse3
1From the Departments of Psychology,
2Pediatrics, and
3Pharmacy Practice, State University of New York at Buffalo, Buffalo, New York.

Tóm tắt

Objective.Methylphenidate (MPH), the most commonly prescribed drug for attention-deficit/hyperactivity disorder (ADHD), has a short half-life, which necessitates multiple daily doses. The need for multiple doses produces problems with medication administration during school and after-school hours, and therefore with compliance. Previous long-acting stimulants and preparations have shown effects equivalent to twice-daily dosing of MPH. This study tests the efficacy and duration of action, in natural and laboratory settings, of an extended-release MPH preparation designed to last 12 hours and therefore be equivalent to 3-times-daily dosing.Methods.Sixty-eight children with ADHD, 6 to 12 years old, participated in a within-subject, double-blind comparison of placebo, immediate-release (IR) MPH 3 times a day (tid), and Concerta, a once-daily MPH formulation. Three dosing levels of medication were used: 5 mg IR MPH tid/18 mg Concerta once a day (qd); 10 mg IR MPH tid/36 mg Concerta qd; and 15 mg IR MPH tid/54 mg Concerta qd. All children were currently medicated with MPH at enrollment, and each child's dose level was based on that child's MPH dosing before the study. The doses of Concerta were selected to be comparable to the daily doses of MPH that each child received. To achieve the ascending rate of MPH delivery determined by initial investigations to provide the necessary continuous coverage, Concerta doses were 20% higher on a daily basis than a comparable tid regimen of IR MPH. Children received each medication condition for 7 days. The investigation was conducted in the context of a background clinical behavioral intervention in both the natural environment and the laboratory setting. Parents received behavioral parent training and teachers were taught to establish a school-home daily report card (DRC). A DRC is a list of individual target behaviors that represent a child's most salient areas of impairment. Teachers set daily goals for each child's impairment targets, and parents provided rewards at home for goal attainment. Each weekday, teachers completed the DRC, and it was used as a dependent measure of individualized medication response. Teachers and parents also completed weekly standardized ratings of behavior and treatment effectiveness. To evaluate the time course of medication effects, children spent 12 hours in a laboratory setting on Saturdays and medication effects were measured using procedures and methods adapted from our summer treatment program. Measures of classroom behavior and academic productivity/accuracy were taken in a laboratory classroom setting during which children completed independent math and reading worksheets. Measures of social behavior were taken in structured, small-group board game settings and unstructured recess settings. Measures included behavior frequency counts, academic problems completed and accuracy, independent observations, teacher and counselor ratings, and individualized behavioral target goals. Reports of adverse events, sleep quality, and appetite were collected.Results.On virtually all measures in all settings, both drug conditions were significantly different from placebo, and the 2 drugs were not different from each other. In children's regular school settings, both medications improved behavior as measured by teacher ratings and individualized target behaviors (the DRC); these effects were seen into the evening as measured by parent ratings. In the laboratory setting, effects of Concerta were equivalent to tid MPH and lasted at least through 12 hours after dosing. Concerta was significantly superior to tid MPH on 2 parent rating scores, and when asked, more parents preferred Concerta than preferred tid IR MPH or placebo. Side effects on children's sleep and appetite were similar for the 2 preparations. In the lab setting, both medications improved productivity and accuracy on arithmetic seatwork assignments, disruptive and on-task behavior, and classroom rule following. Both medications improved children's rule following and negative behavior in small group board games, as well as in unstructured recess settings. Individual target behaviors also showed significant improvement with medication across domains in the laboratory setting. Children's behavior across settings deteriorated across the laboratory day, and the primary effect of medication was to prevent this deterioration as the day wore on. Results support the use of background behavioral treatment in clinical trials of stimulant medication, and illustrate the utility of a measure of individualized daily target goals (ie, the DRC) as an objective measure of medication response in both the laboratory and natural school settings.Conclusion.This investigation clearly supports the efficacy of the Concerta long-acting formulation of MPH for parents who desire to have medication benefits for their child throughout the day and early evening. Effects of a single morning dose lasted throughout the school day and into the evening hours, and were present for both social behavior with peers and academic performance in the classroom. Effects on multiple measures, by multiple informants, and in multiple settings, were similar to those of a standard preparation of MPH given 3 times a day. These effects lasted throughout a 12-hour period, providing coverage of school, afternoon, and evening behavior with a single morning dose. Measures of evening behavior in the laboratory setting included arithmetic productivity (analogous to homework), and recess settings (analogous to home and neighborhood recreational activities). Some parents prefer behavioral interventions to medication for use at home, and some children with ADHD neither need nor tolerate medication in the evening. For those who do need a full 12 hours of medication coverage, based on the results of this study, Concerta would seem to be the choice. This study provides a model for clinical trials of new psychoactive drugs for children: assessments by multiple raters, in both natural and ecologically valid laboratory settings, across a range of domains of impairment and settings, examining a large number of objective, reliable measures of behavior, and in a context of ongoing behavioral treatment. attention-deficit/hyperactivity disorder, pharmacological treatment, methylphenidate, long-acting preparations.

Từ khóa


Tài liệu tham khảo

Goldman, 1998, Diagnosis and treatment of attention-deficit/hyperactivity disorder in children and adolescents., JAMA, 279, 1100, 10.1001/jama.279.14.1100

Spencer, 1996, Pharmacotherapy of ADHD across the life cycle., J Am Acad Child Adolesc Psychiatry, 35, 409, 10.1097/00004583-199604000-00008

Pelham, 1998, Empirically supported psychosocial treatments for ADHD., J Clin Child Psychol, 27, 190, 10.1207/s15374424jccp2702_6

Solanto, 1982, A dose-response and time-action analysis of autonomic and behavioral effects of methylphenidate in attention deficit disorder with hyperactivity., Psychophysiology, 19, 658, 10.1111/j.1469-8986.1982.tb02519.x

Pelham, 1990, Relative efficacy of long-acting stimulants on children with attention deficit-hyperactivity disorder: a comparison of standard methylphenidate, sustained-release methylphenidate, sustained-release dextroamphetamine, and pemoline., Pediatrics, 86, 226, 10.1542/peds.86.2.226

Pelham, 1999, A comparison of morning-only and morning/late afternoon Adderall to morning-only, twice-daily, and three times-daily methylphenidate in children with attention-deficit/hyperactivity disorder., Pediatrics, 104, 1300, 10.1542/peds.104.6.1300

Swanson, 1978, Time-response analysis of the effect of stimulant medication on the learning ability of children referred for hyperactivity., Pediatrics, 61, 21, 10.1542/peds.61.1.21

Musser, 1998, Stimulant use and the potential for abuse in Wisconsin as reported by school administrators and longitudinally followed children., Dev Behav Pediatr, 19, 187, 10.1097/00004703-199806000-00006

Safer, 1994, The increased rate of stimulant therapy for hyperactive/inattentive students in secondary schools., Pediatrics, 94, 462, 10.1542/peds.94.4.462

Hinshaw, 1989, Aggressive, prosocial, and nonsocial behavior in hyperactive boys: dose effects of methylphenidate in naturalistic settings., J Consult Clin Psychol, 57, 636, 10.1037/0022-006X.57.5.636

Pelham, 1990, Methylphenidate and baseball playing in ADD children: who's on first?, J Consult Clin Psychol, 58, 130, 10.1037/0022-006X.58.1.130

Hinshaw, 1995, Peer relationships in boys with attention-deficit hyperactivity disorder with and without comorbid aggression., Dev Psychopathol, 7, 627, 10.1017/S0954579400006751

Birmaher, 1989, Sustained released methylphenidate: pharmacokinetic studies in ADDH males., J Am Acad Child Adolesc Psychiatry, 28, 768, 10.1097/00004583-198909000-00020

Pelham, 1987, Sustained release and standard methylphenidate effects on cognitive and social behavior in children with attention deficit disorder., Pediatrics, 80, 491, 10.1542/peds.80.4.491

Brown, 1979, Plasma levels of d-amphetamine in hyperactive children: serial behavior and motor responses., Psychopharmacology, 62, 133, 10.1007/BF00427126

Pelham, 1995, Pemoline effects on children with ADHD: a time-response by dose-response analysis on classroom measures., J Am Acad Child Adolesc Psychiatry, 34, 1504, 10.1097/00004583-199511000-00018

Swanson, 1998, Analog classroom assessment of Adderall in children with ADHD., J Am Acad Child Adolesc Psychiatry., 37, 519, 10.1097/00004583-199805000-00014

Schachar, 1997, Behavioral, situational, and temporal effects of treatment of ADHD with methylphenidate., J Am Acad Child Adolesc Psychiatry, 36, 754, 10.1097/00004583-199706000-00011

Kent, 1995, Effects of late afternoon methylphenidate administration on behavior and sleep in attention deficit hyperactivity disorder., Pediatrics, 96, 320, 10.1542/peds.96.2.320

Stein, 1996, Methylphenidate dosing: twice daily versus three times daily., Pediatrics, 98, 748, 10.1542/peds.98.4.748

MTA Cooperative Group, 1999, A 14-month randomized clinical trial of treatment strategies for attention-deficit/hyperactivity disorder., Arch Gen Psychiatry, 56, 1073, 10.1001/archpsyc.56.12.1073

Swanson, 1999, Acute tolerance to methylphenidate in the treatment of attention deficit hyperactivity disorder in children., Clin Pharmacol Ther, 66, 295, 10.1016/S0009-9236(99)70038-X

Modi, 2000, Single- and multiple-dose pharmacokinetics of an oral once-a-day osmotic controlled-release OROS (methylphenidate HCl) formulation., J Clin Pharmacol, 40, 379, 10.1177/00912700022009080

Rapport, 1994, Attention deficit disorder and methylphenidate: normalization rates, clinical effectiveness, and response prediction in 76 children., J Am Acad Child Adolesc Psychiatry, 33, 882, 10.1097/00004583-199407000-00015

Shaffer, 2000, NIMH Diagnostic Interview Schedule for Children Version IV (NIMH DISC-IV): description, differences from previous versions, and reliability of some common diagnoses., J Am Acad Child Adolesc Psychiatry, 39, 28, 10.1097/00004583-200001000-00014

Pelham, 1992, Teacher ratings of DSM-III-R symptoms for the disruptive behavior disorders., J Am Acad Child Adolesc Psychiatry, 31, 210, 10.1097/00004583-199203000-00006

O'Leary, 1976, Behavioral treatment of hyperkinetic children: An experimental evaluation of its usefulness., Clin Pediatr, 15, 510, 10.1177/000992287601500603

Pelham, 1999, Psychosocial and combined treatments for ADHD., Ment Retard Dev Disabil Res Rev, 5, 225, 10.1002/(SICI)1098-2779(1999)5:3<225::AID-MRDD9>3.0.CO;2-E

Pelham, 1989, Normative data on the IOWA Conners teacher rating scale., J Clin Child Psychol, 18, 259, 10.1207/s15374424jccp1803_9

Goyette, 1978, Normative data on revised Conners parents and teacher rating scales., J Abnorm Child Psychol, 6, 221, 10.1007/BF00919127

Atkins, 1985, A comparison of objective classroom measures and teacher ratings of attention deficit disorder., J Abnorm Child Psychol, 13, 155, 10.1007/BF00918379

Pelham, 1993, Separate and combined effects of methylphenidate and behavior modification on the classroom behavior and academic performance of ADHD boys: group effects and individual differences., J Consult Clin Psychol, 61, 506, 10.1037/0022-006X.61.3.506

Patrick, 1989, The absorption of sustained-release methylphenidate formulations compared to an immediate-release formulation., Biopharm Drug Dispos, 10, 165, 10.1002/bdd.2510100206

Mash, 1990, Determinants of parenting stress: illustrations from families of hyperactive children and families of physically abused children., J Clin Child Psychol, 19, 313, 10.1207/s15374424jccp1904_3

Pelham, 1997, Effects of deviant child behavior on parental distress and alcohol consumption in laboratory interactions., J Abnorm Child Psychol, 25, 413, 10.1023/A:1025789108958

Pelham, 1998, Effects of deviant child behavior on parental alcohol consumption: Stress-induced drinking in parents of ADHD children., Am J Addict, 7, 103

Barkley, 1979, The effects of methylphenidate on the mother-child interactions of hyperactive children., Arch Gen Psychiatry, 36, 201, 10.1001/archpsyc.1979.01780020091010

Barkley, 1984, Effects of age and Ritalin dosage on the mother-child interactions of hyperactive children., J Consult Clin Psychol, 52, 739, 10.1037/0022-006X.52.5.750

Pisterman, 1999, The role of parent training in treatment of preschoolers with ADD-H., Am J Orthopsychiatry, 62, 397, 10.1037/h0079356

Pisterman, 1992, The effects of parent training on parenting stress and sense of competence., Can J Behav Sci, 24, 41, 10.1037/h0078699

Matsui, 1997, Drug compliance in pediatrics., Pediatr Clin North Am, 44, 1, 10.1016/S0031-3955(05)70459-4

Greenberg, 1984, Overview of patient compliance with medication dosing: a literature review., Clin Ther, 6, 592

Eisen, 1990, The effect of prescribed daily dose frequency on patient medication compliance., Arch Intern Med, 150, 1881, 10.1001/archinte.1990.00390200073014

Evans, 2001, Dose-response effects of methylphenidate on ecologically-valid measures of academic performance and classroom behavior in ADHD adolescents., Exp Clin Psychopharmacol, 9, 1, 10.1037/1064-1297.9.2.163

Smith, 1998, Dosage effects of methylphenidate on the social behavior of adolescents diagnosed with attention deficit hyperactivity disorder., Exp Clin Psychopharmacol, 6, 1, 10.1037/1064-1297.6.2.187

Carlson, 1993, Effects of methylphenidate on the academic performance of children with attention-deficit hyperactivity disorder and learning disabilities., School Psychol Rev, 22, 184, 10.1080/02796015.1993.12085646

Pelham, 1985, Methylphenidate and children with attention deficit disorder: Dose effects on classroom academic and social behavior., Arch Gen Psychiatry, 42, 948, 10.1001/archpsyc.1985.01790330028003

Swanson, 1998, Objective and subjective measures of the pharmacodynamic effects of Adderall in the treatment of children with ADHD in a controlled laboratory classroom setting., Psychopharmacol Bull, 34, 55

Cunningham, 1991, A dose-response analysis of the effects of methylphenidate on the peer interactions and simulated classroom performance of ADD children with and without conduct problems., J Child Psychol Psychiatry, 32, 439, 10.1111/j.1469-7610.1991.tb00322.x

Hinshaw, 1984, Cognitive-behavioral and pharmacologic interventions for hyperactive boys: Comparative and combined effects., J Consult Clin Psychol, 52, 739, 10.1037/0022-006X.52.5.739

Pelham, 2000, Behavioral vs behavioral and pharmacological treatment in ADHD children attending a summer treatment program., J Abnorm Child Psychol., 28, 507, 10.1023/A:1005127030251

Jennings, 1997, Inhibition in boys with attention deficit hyperactivity disorder as indexed by heart rate change., Dev Psychol, 33, 308, 10.1037/0012-1649.33.2.308

Thông tin
Thông tin xuất bản

American Academy of Pediatrics (AAP)

Tập 107 Số 6

e105-e105

Thông tin tác giả